⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL383988 | 0.96 | — | — | |
| SCHEMBL16136742 | 0.85 | — | — | |
| SCHEMBL29236394 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL12814141 | 0.82 | — | — | |
| SCHEMBL9328201 | 0.82 | — | — | |
| SCHEMBL28858575 | 0.82 | OPRM1 (0.36) | — | |
| Trichlormethine SCHEMBL15667520 | 0.82 | LMNA (0.53) | — | |
| SCHEMBL15637503 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL28630959 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL6268145 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 802 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281425-A1 | METHODS FOR TREATING SKIN DISORDERS WITH A TOPICAL COMPOSITION OF BIS-(2-CHLOROETHYL)METHYLAMINE | HELSINN BIREX PHARMACEUTICALS LIMITED (IE) | 2025-09-11 | — | — | US | claimed |
| US-20240301515-A1 | DENDRIMERS FOR GENOMIC ANALYSIS METHODS AND COMPOSITIONS | DOVETAIL GENOMICS LLC (US) | 2024-09-12 | — | — | US | claimed |
| US-20240084291-A1 | METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY PREPARATION | DOVETAIL GENOMICS, LLC | 2024-03-14 | — | — | US | claimed |
| EP-4271804-A1 | METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY PREPARATION | Dovetail Genomics, LLC (US) | 2023-11-08 | — | — | EP | claimed |
| US-11717532-B2 | Methods and compositions for treating wounds utilizing chitosan compounds | SYNEDGEN, INC. (US) | 2023-08-08 | — | — | US | claimed |
| WO-2023091592-A1 | DENDRIMERS FOR GENOMIC ANALYSIS METHODS AND COMPOSITIONS | DOVETAIL GENOMICS, LLC (US) | 2023-05-25 | — | — | WO | claimed |
| WO-2022147129-A1 | METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY PREPARATION | DOVETAIL GENOMICS, LLC (US) | 2022-07-07 | — | — | WO | claimed |
| US-11267924-B2 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | GENZYME CORPORATION (US) | 2022-03-08 | — | — | US | claimed |
| US-11197887-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2021-12-14 | — | — | US | claimed |
| US-11071795-B2 | Indicating devices based on etching of metals | JP LABORATORIES INC. (US) | 2021-07-27 | — | — | US | claimed |
| WO-2007130463-A2 | AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS | GENZYME CORPORATION (US) | 2007-11-15 | — | — | WO | claimed |
| US-20070114121-A1 | Signal activated decontaminating coating | CROSSLINK POLYMER RESEARCH (US) | 2007-05-24 | — | — | US | claimed |
| EP-1727911-A2 | BASE SPECIFIC CLEAVAGE OF METHYLATION-SPECIFIC AMPLIFICATION PRODUCTS IN COMBINATION WITH MASS ANALYSIS | SEQUENOM, INC. (US) | 2006-12-06 | — | — | EP | claimed |
| WO-2006099385-A2 | STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF | YAUPON THERAPEUTICS, INC. (US) | 2006-09-21 | — | — | WO | claimed |
| US-20060205694-A1 | topical nitrogen mustard or salts in nonaqueous vehicles or carriers, used for treating skin disorders | HELSINN BIREX PHARMACEUTICALS LIMITED (IE) | 2006-09-14 | — | — | US | claimed |
| US-20050272070-A1 | Base specific cleavage of methylation-specific amplification products in combination with mass analysis | SEQUENOM, INC. (US) | 2005-12-08 | — | — | US | claimed |
| WO-2005098050-A2 | BASE SPECIFIC CLEAVAGE OF METHYLATION-SPECIFIC AMPLIFICATION PRODUCTS IN COMBINATION WITH MASS ANALYSIS | SEQUENOM, INC. (US) | 2005-10-20 | — | — | WO | claimed |
| EP-0924196-B1 | Process for the alkylation of alkyl- or benzonitrile in the presence of trialkyl amines or phosphines | AVENTIS PHARMA GMBH (DE) | 2003-06-18 | — | — | EP | claimed |
| US-6143896-A | ALKYLATION OF NITRILE COMPOUND WITH SUBSTITUTED OR UNSUBSTITUTED ALKYL HALIDE OR DIALKYLSULFATE IN PRESENCE OF TRIALKYLOR ARYL AMINE OR PHOSPHINE COMPOUNDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-11-07 | — | — | US | claimed |
| EP-0924196-A1 | Process for the alkylation of alkyl- or benzonitrile in the presence of trialkyl amines or phosphines | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-06-23 | — | — | EP | claimed |